Loading...
Loading...
Jefferies & Co. is raising its price target on shares of ArthroCare
ARTC to $37 from $35, and is keeping its Buy rating on shares.
In a note to clients, Jefferies writes, "After nearly capsizing in the storm caused by a reimbursement scheme in Florida, ArthroCare has turned over management, cleaned up its finances, and is poised for continued strong revenue growth and profitability improvements."
Shares of ARTC gained 49 cents yesterday to close at $31.64, a gain of 1.57%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in